1 |
Terada, T., Fujimoto, K., Nomura, M., Kobunai, T., Takeda, S., Wierzbi, K., Yamada, Y. and Yamaguchi, H. Antitumor agent. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents. Chem. Pharm. Bull., 40,2720-2727 (1992)
DOI
PUBMED
ScienceOn
|
2 |
Andrew, P., Robert, S. W., Martyn, C. P. and Trevor, K. Synthesis of lignans related to the podophyllotoxin series. J. Chem. Soc. Perkin Trans. 1, 1603-1613 (1988)
|
3 |
Jardine, I. and Cassidy, J. M. In anticancer agents based on natural product models, Academic Press, New York, pp. 319-351(1980)
|
4 |
Novelo, M., Cruz, G. J., Hernandez, L. and Rogelio, P. M. Cytotoxic constituents from Hyptis Verticillata. J. Nat. Pro., 56, 1728-1736 (1993)
DOI
ScienceOn
|
5 |
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S. and Boyd, M. R., New calorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82,1107-1112 (1990)
DOI
PUBMED
|
6 |
Noguchi, T. and Kawanami, M. Studies on the constituent of Anthricus sylvestris Hoffm. Vakugaku Zesshi, 60, 629-636(1940)
|
7 |
Macdoniel, P. B. and Cole, J. R. Antitumor activity of Bursera schlechtendalii (Burceraceae): isolation and structure determination of two new lignans. J. Pharm. Sci., 61, 1992-1994(1972)
DOI
PUBMED
|
8 |
Zavala, F. and Guenard, D. Structure-antitubulin activity relationship in stegabacin congeners and analogues. Inhibition of tubulin polymerization in vitro by ( )-isodeoxypodophyllotoxin. J. Med. Chem., 23, 546-549 (1980)
DOI
PUBMED
|
9 |
Medarde, M., Clairac, R. P.-L., Tome, F., Lopez, J. L. and Feliciano, A. S., Heterolignolides: Antitumor activity of furyl-,thienyl-, and Pyridyl analogs of lignanolides. Arch. Pharm. (Weinheim) 328,403-407 (1995)
DOI
ScienceOn
|
10 |
Bianchi, E., Caldwell, M. E. and Cole, J. R. Antitumor agents from Bursera microphylla (Burseraceae) I. Isolation and characterization of deoxypodophyllotoxin. J. Pharm. Sci., 57, 696-697(1968)
DOI
PUBMED
|
11 |
Eckart, E., Heinz, P., Macki, K., Jutta, S., Mark, R. F., Abhijit, M. and Yves, P.(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem., 39, 86-95 (1996)
DOI
ScienceOn
|
12 |
Ziegler, F. E. and Schwartz, J. A. Synthetic studies on lignan lactones: Aryl dithiane route to ( )-podorhizol and ( )-isodeoxypodophyllotoxon and approaches to the stegane skeleton. J. Org. Chem., 43, 985-991 (1978)
DOI
|
13 |
Kim, Y., You, Y. J., Kim, S. B. and Ahn, B. Z. Deoxypodophyllotoxin; The cytotoxic and antiangiogenic component from Pulsatilla koreana. Planta Med., 68, 271-274(2002)
DOI
ScienceOn
|
14 |
Andrew, P., Ward, P., Satyanarayana, P. and Collins, P. Synthesis of lignan lactones by conjugate addition of thioacetal carbanions to butenolide. J. Chem. Soc. Perkin Trans. 1,643-647 (1983)
|